Literature DB >> 28716455

The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function.

Misha F Vrolijk1, Antoon Opperhuizen2, Eugène H J M Jansen3, Geja J Hageman4, Aalt Bast4, Guido R M M Haenen4.   

Abstract

Vitamin B6 is a water-soluble vitamin that functions as a coenzyme in many reactions involved in amino acid, carbohydrates and lipid metabolism. Since 2014, >50 cases of sensory neuronal pain due to vitamin B6 supplementation were reported. Up to now, the mechanism of this toxicity is enigmatic and the contribution of the various B6 vitamers to this toxicity is largely unknown. In the present study, the neurotoxicity of the different forms of vitamin B6 is tested on SHSY5Y and CaCo-2 cells. Cells were exposed to pyridoxine, pyridoxamine, pyridoxal, pyridoxal-5-phosphate or pyridoxamine-5-phosphate for 24h, after which cell viability was measured using the MTT assay. The expression of Bax and caspase-8 was tested after the 24h exposure. The effect of the vitamers on two pyridoxal-5-phosphate dependent enzymes was also tested. Pyridoxine induced cell death in a concentration-dependent way in SHSY5Y cells. The other vitamers did not affect cell viability. Pyridoxine significantly increased the expression of Bax and caspase-8. Moreover, both pyridoxal-5-phosphate dependent enzymes were inhibited by pyridoxine. In conclusion, the present study indicates that the neuropathy observed after taking a relatively high dose of vitamin B6 supplements is due to pyridoxine. The inactive form pyridoxine competitively inhibits the active pyridoxal-5'-phosphate. Consequently, symptoms of vitamin B6 supplementation are similar to those of vitamin B6 deficiency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neuropathy; Neurotoxic; Pyridoxine; Supplements; Vitamin B6

Mesh:

Substances:

Year:  2017        PMID: 28716455     DOI: 10.1016/j.tiv.2017.07.009

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  18 in total

1.  Regressive pyridoxine-induced sensory neuronopathy in a patient with homocystinuria.

Authors:  Andoni Echaniz-Laguna; Rachel Mourot-Cottet; Esther Noel; Jean-Baptiste Chanson
Journal:  BMJ Case Rep       Date:  2018-06-28

Review 2.  Neurology of Nutritional Deficiencies.

Authors:  Kristin L Miller; Gabriela Trifan; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 3.  Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.

Authors:  Florence van Hunsel; Sonja van de Koppel; Eugène van Puijenbroek; Agnes Kant
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

Review 4.  Inborn Errors of Metabolism in Pediatric Epilepsy.

Authors:  Anna S Cosnahan; Christopher T Campbell
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

5.  Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.

Authors:  Hayahide Ooi; Ryuto Nasu; Ayako Furukawa; Masayoshi Takeuchi; Yoshiki Koriyama
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Effect of Double Substitution in Cationic Chitosan Derivatives on DNA Transfection Efficiency.

Authors:  Veronika D Badazhkova; Sergei V Raik; Dmitry S Polyakov; Daria N Poshina; Yury A Skorik
Journal:  Polymers (Basel)       Date:  2020-05-05       Impact factor: 4.329

7.  Association of High Intakes of Vitamins B6 and B12 From Food and Supplements With Risk of Hip Fracture Among Postmenopausal Women in the Nurses' Health Study.

Authors:  Haakon E Meyer; Walter C Willett; Teresa T Fung; Kristin Holvik; Diane Feskanich
Journal:  JAMA Netw Open       Date:  2019-05-03

8.  PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation.

Authors:  Viorica Chelban; Matthew P Wilson; Jodi Warman Chardon; Jana Vandrovcova; M Natalia Zanetti; Eleni Zamba-Papanicolaou; Stephanie Efthymiou; Simon Pope; Maria R Conte; Giancarlo Abis; Yo-Tsen Liu; Eloise Tribollet; Nourelhoda A Haridy; Juan A Botía; Mina Ryten; Paschalis Nicolaou; Anna Minaidou; Kyproula Christodoulou; Kristin D Kernohan; Alison Eaton; Matthew Osmond; Yoko Ito; Pierre Bourque; James E C Jepson; Oscar Bello; Fion Bremner; Carla Cordivari; Mary M Reilly; Martha Foiani; Amanda Heslegrave; Henrik Zetterberg; Simon J R Heales; Nicholas W Wood; James E Rothman; Kym M Boycott; Philippa B Mills; Peter T Clayton; Henry Houlden
Journal:  Ann Neurol       Date:  2019-07-01       Impact factor: 10.422

Review 9.  Peripheral nerve disease secondary to systemic conditions in children.

Authors:  Jo M Wilmshurst; Robert A Ouvrier; Monique M Ryan
Journal:  Ther Adv Neurol Disord       Date:  2019-08-12       Impact factor: 6.570

Review 10.  Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.

Authors:  Fariba Lotfi; Mostafa Akbarzadeh-Khiavi; Ziba Lotfi; Leila Rahbarnia; Azam Safary; Habib Zarredar; Amir Baghbanzadeh; Behrooz Naghili; Behzad Baradaran
Journal:  Infection       Date:  2021-06-23       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.